Glenmark Pharmaceuticals announced that the Board of Directors of the Company at its meeting held on 26 September 2025, inter alia, have recommended the interim dividend of Rs 2.5 per equity Share (i.e. 250%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News